Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BAROSTIM NEO Hypertension Pivotal Trial

NCT01679132 is registered in ClinicalTrials.gov with CVRx, Inc. as lead sponsor.

NCT NCT01679132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BAROSTIM NEO Hypertension Pivotal Trial
Lead sponsor
CVRx, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2013
Completion date
July 23, 2025
Enrollment
10 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

uncontrolled hypertension